GSK241101C53000
- 0.00
- 0.000.00%
GlaxoSmithKline Newsroom
Here's the Major Earnings Before the Open Tomorrow
US CDC Reports 36 H5 Bird Flu Cases In U.S. Since April; Six Cases In Washington Poultry Workers Confirmed Last Week; No Person-To-Person Spread Detected; Public Risk Remains Low But Higher For Those Exposed To Infected Animals; 15 Cases Linked To...
GSK Q3 2024 Earnings Preview
Unusual Options Activity: AMKR, GEHC and Others Attract Market Bets, AMKR V/OI Ratio Reaches 830.8
GSK once again came to China to acquire innovative drugs! Signed a $0.85 billion agreement to expand the lupus pipeline.
① The total value of this trade can reach up to $0.85 billion, with an initial payment of $0.3 billion; ② This acquisition will further expand GSK's own immune disease treatment pipeline; ③ With the global recognition of China Meheco Group's R&D capabilities, such trades have been rapidly increasing in recent years.
GSK to Start Phase I Trial in Lupus in 2025
GSK to Pay Extra Sums Based on Development, Commercial Milestones
GSK: CMG1A46 Is Currently in Phase I Clinical Trials in Leukaemia, Lymphom
GSK to Buy Experimental Lupus Drug From China's Chimagen Biosciences
GSK to Acquire Chimagen Biosciences' Drug Candidate CMG1A46 for $300 Million
Express News | GSK Acquires CMG1A46 From Chimagen Biosciences For $300M To Boost Immunology Pipeline, Targeting B Cell-Driven Autoimmune Diseases Like Lupus; Chimagen Eligible For Additional $550M In Milestone Payments
GSK Inks Lupus Deal With Chinese Biotech for Up to $850 Million
Express News | Google To Launch New "Sexual Health & Wellness" Policy On November 11, Permitting Promotion Of Personal Lubricants And Prescription Drugs In Select Countries
GSK Net Profit Expected to Rise, Turnover to Fall -- Earnings Preview
BofA Securities Maintains GlaxoSmithKline(GSK.US) With Sell Rating
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), GlaxoSmithKline (GSK) and Amylyx Pharmaceuticals Inc (AMLX)
Moderna's Stock-Price Target Slashed. It's About Vaccines. -- Barrons.com
Moderna Stock Price Target Slashed. It's About Vaccines. -- Barrons.com
IDEAYA Biosciences Reveals Clearance Of Investigational New DrugApplication With FDA For Initiation Of Phase 1 Clinical Trial To Evaluate Werner Helicase Development Candidate IDE275
It's Time to Get Your Covid and Flu Shots. Everything to Know About This Year's Vaccines. -- Barrons.com